The Injective protocol has experienced a significant price movement. Starting from a demand level of $7.5 in Oct 2023, it saw a substantial rally, eventually reaching $52.50 by March 12th, after breaking through the resistance level of $45 (a barrier tested three times previously).
However, the peak at $52.50 proved to be unsustainable, and the price began to decline on March 13th, establishing a new support level at $20 by April 13th. Meanwhile, Attempts to recover were thwarted repeatedly by the dynamic resistance posed by the 50-day and 200-day EMAs. In the most recent week, the price suffered a -22% setback, retreating once again to the $20 support level. The bearish outlook is further underscored by the MACD, which displays a bearish crossover with a histogram value of -0.876, while the RSI indicator is at 35.87, suggesting a bearish momentum. INJ Price Forecast!
At press time, the INJ traded at $20.761 with an intraday gain of 1.56%.
Case 1 - If Price manages to successfully rebound from the current level and beats dynamic resistance in the process, the nearest targets would be then $30.0 and $36.0.
Case 2- If the price is unable to manage the current support level, then it could reach the $15.0 and $10.0 marks.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.